Outcomes of Endoscopic Ultrasound-Guided Biliary Drainage in Patients Undergoing Antithrombotic Therapy
Open Access
- 30 July 2021
- journal article
- research article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 54 (4), 596-602
- https://doi.org/10.5946/ce.2020.194
Abstract
Background/Aims: The Japan Gastroenterological Endoscopy Society (JGES) has published guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. These guidelines classify endoscopic ultrasound-guided biliary drainage (EUS-BD) as a high-risk procedure. Nevertheless, the bleeding risk of EUS-BD in patients undergoing antithrombotic therapy is uncertain. Therefore, this study aimed to assess the bleeding risk in patients undergoing antithrombotic therapy. Methods: This single-center retrospective study included 220 consecutive patients who underwent EUS-BD between January 2013 and December 2018. We managed the withdrawal and continuation of antithrombotic agents according to the JGES guidelines. We compared the bleeding event rates among patients who received and those who did not receive antithrombotic agents. Results: A total of 18 patients (8.1%) received antithrombotic agents and 202 patients (91.8%) did not. Three patients experienced bleeding events, with an overall bleeding event rate of 1.3% (3/220): one patient was in the antithrombotic group (5.5%) and two patients were in the non-antithrombotic group (0.9%) (p=0.10). All cases were moderate. The sole thromboembolic event (0.4%) was a cerebral infarction in a patient in the non-antithrombotic group. Conclusions: The rate of EUS-BD-related bleeding events was low. Even in patients receiving antithrombotic therapy, the bleeding event rates were not significantly different from those in patients not receiving antithrombotic therapy.Keywords
This publication has 19 references indexed in Scilit:
- Outcomes of EUS-FNA in patients receiving antithrombotic therapyEndoscopy International Open, 2019
- A Prospective Multicenter Study Evaluating Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Prescribed Antithrombotic AgentsGut and Liver, 2018
- Risks of transesophageal endoscopic ultrasonography-guided biliary drainageInternational Journal of Gastrointestinal Intervention, 2017
- Bleeding risk of endoscopic ultrasound‐guided fine‐needle aspiration in patients undergoing antithrombotic therapyDigestive Endoscopy, 2016
- Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatmentDigestive Endoscopy, 2013
- Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy, 2011
- A lexicon for endoscopic adverse events: report of an ASGE workshopGastrointestinal Endoscopy, 2010
- Management of antithrombotic agents for endoscopic proceduresGastrointestinal Endoscopy, 2009
- Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic proceduresGut, 2008
- A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparinGastrointestinal Endoscopy, 2006